Target intelligence / Profile preview

Cyclodextrin (CD)

Target
CD
Molecular classification
Other (Cyclic oligosaccharide, not a protein or conventional drug target class)
01

Overview

Cyclodextrin refers to a group of cyclic oligosaccharides composed of 6 (α-cyclodextrin), 7 (β-cyclodextrin), or 8 (γ-cyclodextrin) D-glucose units linked by α-1,4 glycosidic bonds, forming a truncated cone shape. The exterior is hydrophilic due to hydroxyl groups, while the interior is hydrophobic, allowing cyclodextrins to form inclusion complexes with hydrophobic molecules in aqueous solutions. Cyclodextrins are not biological receptors or enzymes, but are highly valued in the pharmaceutical, food, and chemical industries for their ability to improve the solubility, stability, and delivery of otherwise poorly soluble molecules. Various derivatives (e.g., hydroxypropyl-β-cyclodextrin) are used to modulate solubility and inclusion properties further. Cyclodextrins are considered nontoxic at pharmaceutical doses but may cause renal or auditory toxicity at high doses, especially with β-cyclodextrin.

Other names
Alpha-cyclodextrinBeta-cyclodextrinGamma-cyclodextrinCyclohexaamyloseCycloheptaamyloseCyclomaltohexaoseCyclomaltoheptaoseBetadex
02

Mechanism of action

Enhance solubility and stability of guest molecules via inclusion complex formation within the hydrophobic central cavity; act as molecular carriers

03

Biological functions

Drug delivery carrierSolubilizer of hydrophobic drugs/compoundsComplexation agent for molecules in pharmaceutical, food, and cosmetic industries
04

Disease associations

Other (no direct pathophysiological role; used to improve drug efficacy in many diseases, including rare transport disorders and cholesterol management in research contexts)
05

Safety considerations

Generally safe and non-toxic in typical doses; excessive amounts, especially of β-cyclodextrin, can have nephrotoxic effects and damage the auditory nerve
06

Interacting drugs

Cyclodextrins do not have direct drug "interactors," but form inclusion complexes with many drugs to increase their solubility/bioavailability (examples: estrogens, steroids, various hydrophobic drugs)

Beyond the preview

Go deeper on Cyclodextrin (CD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclodextrin (CD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call